49.33
[1]. Katarzyna Socała, et al. Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models. Pharmacol Rep. Mar-Apr 010;6():39-7.
[]. Mei-Yi Lee, et al. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials. J Biomed Sci. 017; 4: 18.
[3]. Arun Sreekumar, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 009 Feb 1;457(731):910-4.
[4]. Elena Buelow, et al. Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother. 014 Aug;69(8):15-3.
[5]. Franziska Barthel, et al. Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats. Anesthesiology. 014 Jul;11(1):160-9.
H30-H315-H319-H335
P61-P64-P70-P71-P80-P30+P35-P304+P340-P305+P351+P338-P330-P36+P364-P403+P33-P405-P501